Breaking News Instant updates and real-time market news.

TEVA

Teva

$18.59

-2.01 (-9.76%)

, JCP

J.C. Penney

$5.39

-0.05 (-0.92%)

07:30
08/08/17
08/08
07:30
08/08/17
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Monday in Teva (TEVA), J C Penney (JCP), Nucor (NUE), Avis Budget (CAR), and RSP Permian (RSPP).

TEVA

Teva

$18.59

-2.01 (-9.76%)

JCP

J.C. Penney

$5.39

-0.05 (-0.92%)

NUE

Nucor

$57.86

0.38 (0.66%)

CAR

Avis Budget

$33.39

1.18 (3.66%)

RSPP

RSP Permian

$30.77

-0.34 (-1.09%)

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 10

    Aug

  • 11

    Aug

  • 30

    Aug

TEVA Teva
$18.59

-2.01 (-9.76%)

08/07/17
08/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst David Risinger saying he underappreciated generic pricing pressure risks on Teva's dividend and expects declining earnings power, combined with high leverage equal to result in a longer recovery. 2. Cummins (CMI) downgraded to Buy from Conviction Buy at Goldman Sachs. 3. RE/MAX Holdings (RMAX) downgraded to Equal Weight from Overweight at Stephens. 4. Intrepid Potash (IPI) downgraded to Sell from Neutral at UBS with analyst John Roberts saying that while bankruptcy risk has been "significantly reduced" since the share count was increased 60% with the March secondary, he remains concerned about the lack of long term growth in non-core income and "still depressed" core potash related income. Roberts cites valuation for his downgrade and raised his price target for Intrepid Potash shares to $2.50 from $2.00. 5. Eaton (ETN) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/17
08/04/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fluor (FLR) was downgraded to Hold from Buy at Deutsche Bank and to Neutral from Buy at DA Davidson. 2. Teva (TEVA) was downgraded to Market Perform from Outperform at Cowen, to Neutral from Outperform at Credit Suisse, and to Underperform from Outperform at RBC Capital. 3. Ford (F) downgraded to Neutral from Buy at Nomura Instinet with analyst Anindya Das citing uncertainties surrounding North America and European growth. 4. Avon Products (AVP) downgraded to Hold from Buy at Deutsche Bank with analyst Faiza Alwy saying the Chief Executive Officer change suggests that a business recovery, should there be one, is more than 12 months away. 5. CommScope (COMM) was downgraded to Hold from Buy at Cross Research, to Neutral from Buy at Longbow, and to Equal Weight from Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/07/17
MSCO
08/07/17
DOWNGRADE
MSCO
Underweight
Teva downgraded to Underweight from Equal Weight at Morgan Stanley
08/07/17
MSCO
08/07/17
DOWNGRADE
Target $16
MSCO
Teva downgraded to Underweight, bear case target $9 at Morgan Stanley
As previously reported, Morgan Stanley downgraded Teva to Underweight from Equal Weight and cut its price target to $16 from $36. Analyst David Risinger said he underappreciated generic pricing pressure risks on Teva's dividend and expects declining earnings power, combined with high leverage equal to result in a longer recovery. He expects core business generic headwinds and Copaxone generic competition to pressure Teva's long-term earnings power and cut his 2017 earnings estimate to $1.24 from $1.55, 2018 earnings estimate to $4.14 from $4.56, and 2019 earnings estimate to $3.79 from $4.50. Risinger's bear case price target on Teva is $9, which assumes much more severe Copaxone erosion and generic business downside.
JCP J.C. Penney
$5.39

-0.05 (-0.92%)

06/21/17
GDHS
06/21/17
NO CHANGE
GDHS
Nike-Amazon pact yet another department store headwind, says Gordon Haskett
Gordon Haskett analyst noted the reports of Nike (NKE) nearing a deal to sell directly on Amazon (AMZN), which he said wouldn't impact trends overnight but would represent another headwind for department stores, particularly J.C. Penney (JCP) and Kohl's (KSS), where the brand has a larger penetration than at Macy's (M) and Nordstrom (JWN). He keeps an Accumulate rating on Nordstrom, a Hold rating on Macy's and Reduce rating on both J.C. Penney and Kohl's.
06/26/17
GDHS
06/26/17
UPGRADE
Target $4.5
GDHS
Accumulate
J.C. Penney upgraded to Hold from Reduce at Gordon Haskett
Gordon Haskett analyst Chuck Grom upgraded J.C. Penney to Hold from Reduce with a $4.50 price target.
07/12/17
SBSH
07/12/17
NO CHANGE
Target $5
SBSH
Neutral
J.C. Penney price target raised to $5 from $4.50 at Citi
Citi analyst Paul Lejuez raised his price target for J.C. Penney to $5 from $4.50 after the retailer announced that Q2 sales had "significantly improved" versus Q1. The analyst upped his FY17 earnings per share estimate to 53c from 40c and keeps a Neutral rating on Penny.
05/15/17
05/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Adam Jonas saying the bull thesis on Tesla centers around the company becoming the next Amazon (AMZN) or Apple (AAPL), Jonas tells investors in a research note. The analyst, however, questions if the risks of taking on the tech giants is sufficiently discounted in the share price. He expects "much larger and more well capitalized" competitors to unveil strategies that directly address sustainable transport and mobility. 2. J.C. Penney (JCP) was downgraded to Hold from Buy at Deutsche Bank, to Neutral from Outperform at Baird, and to Neutral from Buy at Buckingham. 3. STMicroelectronics (STM) downgraded to Hold from Buy at Stifel. 4. Level 3 (LVLT) and CenturyLink (CTL) were downgraded to Underperform from Market Perform at Raymond James. 5. TSMC (TSM) downgraded to Neutral from Outperform at Credit Suisse with analyst Randy Abrams saying headwinds from excess inventory, slower China smartphones, and Qualcomm (QCOM) shifts to Samsung (SSNLF) could pressure sales and margins. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NUE Nucor
$57.86

0.38 (0.66%)

07/20/17
07/20/17
NO CHANGE

Cowen would be buying Steel stock weakness
Cowen said the lackluster earnings from Steel Dynamics (STLD) and Nuecor (NUE) is causing weakness in the steel sector. The firm's analyst would use the weakness to buying opportunity given the reports are backwards looking, HRC prices are moving higher, service center inventories are low, and an announcement on steel tariffs is imminent. The firm would not want to be short the group and reiterates outperform ratings on TimkenSteel (TMST) and Steel Dynamics
07/18/17
MSCO
07/18/17
NO CHANGE
MSCO
Morgan Stanley more bullish on second half steel pricing
Following a dinner with steel participants last week, Morgan Stanley analyst Evan Kurtz said he is more bullish on second half 2017 steel pricing. The takeaways were that imports are likely to dip significantly in September and October due to traders not wanting to take the risk of being an "import of record" with the threat of tariffs. Further, the analyst said inventories are low, so even with stable demand, the market could get tight, the analyst wrote. Kurtz raised his HRC forecast for the second half to $625/st from $570/st, and raised his scrap forecast by $30/t. The analyst recommends buying Overweight rated U.S. Steel (X), Steel Dynamics (STLD) and Nucor (NUE).
07/13/17
MSCO
07/13/17
NO CHANGE
MSCO
Morgan Stanley says its time to buy Steels
Morgan Stanley analyst Evan Kurtz met with steel executives last night and came away more bullish on potential second half 2017 pricing strength. Kurtz said steel buyers have been keeping inventories low given the uncertainty of the 232 investigation and he expects imports to drop sharply in September and October as importers likely look to reduce risk from potential 232 penalties ahead. The analyst said demand appears steady and many steel buyers have yet to complete Q3 purchases, and he expects scrap to remain stable near-term. Kurts believes Overweight rated U.S. Steel (X), Steel Dynamics(STLD), and Nucor (NUE) could be strong second half performers given positioning and leverage.
07/03/17
BMOC
07/03/17
NO CHANGE
BMOC
Steel stocks still have positive risk/reward ratio, says BMO Capital
BMO Capital analyst David Gagliano says that "during the past two weeks, the majority of the steel lead-indicators we monitor have either stabilized or started to move higher." He adds that the Trump administration may levy tariffs which will cause imports to drop significantly over the next three to six months. As a result, the analyst believes that the steel stocks "continue to provide a favorable risk/reward opportunity." Publicly traded steel stocks include AK Steel (AKS), United States Steel (X), Nucor Corporation (NUE), and Steel Dynamics (STLD).
CAR Avis Budget
$33.39

1.18 (3.66%)

08/04/17
JPMS
08/04/17
INITIATION
Target $39
JPMS
Overweight
Avis Budget initiated with an Overweight at JPMorgan
JPMorgan analyst Samik Chatterjee started Avis Budget with an Overweight rating and $39 price target. The analyst highlights the company's experienced management team and sees upside from its ownership of Zipcar.
06/27/17
MKMP
06/27/17
NO CHANGE
MKMP
Autonomous vehicle deals positive for car rental companies, says MKM Partners
After Avis (CAR) announced a multi-year deal with on autonomous vehicles with Alphabet's (GOOG, GOOGL) Waymo and news reports stated that Hertz (HTZ) is working with Apple (AAPL) on autonomous vehicles, MKM Partners analyst Christopher Agnew says the news should ease investors' concerns about car rental companies no longer existing in five to ten years. The analyst believes that car rental companies will become "more relevant" following the launch of autonomous vehicles due to their fleet management skills. He keeps Buy ratings on Hertz and Avis.
08/04/17
08/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Neutral at Wedbush. 2. Avis Budget (CAR) was initiated with an Overweight at JPMorgan while Hertz (HTZ) was initiated with a Neutral at the firm. 3. IBM (IBM) initiated with a Neutral at Wedbush. 4. Amtech Systems (ASYS) initiated with a Buy at Roth Capital. 5. Franklin Financial Network (FSB) initiated with a Market Perform at Hovde Group. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/26/17
DBAB
06/26/17
NO CHANGE
DBAB
Buy
Avis announcement of Waymo management pact a positive, says Deutsche Bank
Deutsche Bank analyst Chris Woronka said he views news of the multi-year fleet management contract with Alphabet's (GOOG) Waymo as a positive for Avis Budget (CAR) that came as a surprise to most. He sees the deal as an indication that logistics management and access to on-airport real estate are real assets for the rental car companies, adding that he expects news flow on Avis' involvement in autonomous driving to increase as more of these vehicles hit the road. Woronka keeps a Buy rating on Avis shares.
RSPP RSP Permian
$30.77

-0.34 (-1.09%)

06/15/17
WOLF
06/15/17
INITIATION
Target $45
WOLF
Outperform
RSP Permian initiated with an Outperform at Wolfe Research
Wolfe Research initiated RSP Permian with an Outperform and a $45 price target.
06/01/17
FBCO
06/01/17
INITIATION
Target $59
FBCO
Outperform
RSP Permian initiated with an Outperform at Credit Suisse
Credit Suisse analyst Nitin Kumar initiated RSP Permian with an Outperform and a $59 price target saying Street estimates underestimate growth potential and urges investors to look past deployment of development capital in the Delaware Basin and towards potential resource estimate upside.
07/25/17
ROTH
07/25/17
NO CHANGE
Target $44
ROTH
Buy
RSP Permian price target lowered to $44 from $64.50 at Roth Capital
Roth Capital analyst John White lowered his price target for RSP Permian to $44 from $64.50 on valuation. The analyst reiterates a Buy rating on the shares.
07/19/17
BOFA
07/19/17
INITIATION
Target $45
BOFA
Buy
RSP Permian reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Asit Sen reinstated RSP Permian with a Buy and a $45 price target.

TODAY'S FREE FLY STORIES

AAPL

Apple

$165.25

-3.12 (-1.85%)

, QCOM

Qualcomm

$58.05

2.05 (3.66%)

12:06
12/10/18
12/10
12:06
12/10/18
12:06
OnTheFly
Fly Intel: Wall Street's top stories at midday »

The averages were…

AAPL

Apple

$165.25

-3.12 (-1.85%)

QCOM

Qualcomm

$58.05

2.05 (3.66%)

FB

Facebook

$140.74

3.32 (2.42%)

GPRO

GoPro

$4.94

-0.04 (-0.80%)

TVPT

Travelport

$15.68

0.275 (1.79%)

NTRI

Nutrisystem

$44.14

9.95 (29.10%)

TVTY

Tivity Health

$28.53

-12.07 (-29.73%)

XPER

Xperi

$18.34

5.54 (43.28%)

SSNLF

Samsung

$0.00

(0.00%)

MDRX

Allscripts

$10.15

0.66 (6.95%)

MGNX

MacroGenics

$12.00

-4.44 (-27.01%)

CRZO

Carrizo Oil & Gas

$14.69

-1.2 (-7.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 06

    Jan

KZR

Kezar Life Sciences

$27.79

0.41 (1.50%)

12:05
12/10/18
12/10
12:05
12/10/18
12:05
Conference/Events
Kezar Life Sciences management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

T

AT&T

$29.50

-0.64 (-2.12%)

12:05
12/10/18
12/10
12:05
12/10/18
12:05
Options
AT&T call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 20

    Mar

BC

Brunswick

$49.53

-0.05 (-0.10%)

12:02
12/10/18
12/10
12:02
12/10/18
12:02
Conference/Events
Brunswick management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

AJG

Arthur J. Gallagher

$73.87

-0.74 (-0.99%)

12:01
12/10/18
12/10
12:01
12/10/18
12:01
Hot Stocks
Arthur J. Gallagher acquires Captive Insurance Company Design and Operations »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

JP

Jupai Holdings

$5.06

-0.94 (-15.67%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Jupai Holdings falls -15.8% »

Jupai Holdings is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSC

Global Geoscience

$23.90

(0.00%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Global Geoscience falls -16.2% »

Global Geoscience is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPX

Marine Products

$18.19

-3.4 (-15.75%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Marine Products falls -18.3% »

Marine Products is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPER

Xperi

$18.39

5.59 (43.67%)

, SSNLF

Samsung

$0.00

(0.00%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Recommendations
Xperi, Samsung analyst commentary  »

Xperi settlement removes…

XPER

Xperi

$18.39

5.59 (43.67%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

FAZ

Direxion Financial Bear 3x

$12.50

0.67 (5.66%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Direxion Financial Bear 3x rises 5.8% »

Direxion Financial Bear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCUS

Arcus Biosciences

$13.15

0.9 (7.35%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Arcus Biosciences rises 8.1% »

Arcus Biosciences is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYX

Systemax

$29.66

3.57 (13.68%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Systemax rises 13.9% »

Systemax is up 13.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

GOOG

Alphabet

$1,034.54

-1.98 (-0.19%)

, GOOGL

Alphabet Class A

$1,044.62

-2.37 (-0.23%)

11:58
12/10/18
12/10
11:58
12/10/18
11:58
Periodicals
Google acquires Indian app developer Sigmoid Labs, VB reports »

Google has acquired…

GOOG

Alphabet

$1,034.54

-1.98 (-0.19%)

GOOGL

Alphabet Class A

$1,044.62

-2.37 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 03

    Mar

ZLAB

Zai Lab

$19.71

-1.15 (-5.51%)

11:57
12/10/18
12/10
11:57
12/10/18
11:57
Conference/Events
Zai Lab management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SAGE

Sage Therapeutics

$102.08

-0.55 (-0.54%)

, MRNS

Marinus Pharmaceuticals

$5.15

-0.03 (-0.58%)

11:57
12/10/18
12/10
11:57
12/10/18
11:57
Recommendations
Sage Therapeutics, Marinus Pharmaceuticals analyst commentary  »

JMP boosts Marinus target…

SAGE

Sage Therapeutics

$102.08

-0.55 (-0.54%)

MRNS

Marinus Pharmaceuticals

$5.15

-0.03 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Mar

TVTY

Tivity Health

$28.25

-12.35 (-30.42%)

, NTRI

Nutrisystem

$44.06

9.87 (28.87%)

11:55
12/10/18
12/10
11:55
12/10/18
11:55
OnTheFly
Tivity plunges as investors digest news of Nutrisystem acquisition »

Shares of Tivity Health…

TVTY

Tivity Health

$28.25

-12.35 (-30.42%)

NTRI

Nutrisystem

$44.06

9.87 (28.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ERJ

Embraer

$21.11

0.04 (0.19%)

11:53
12/10/18
12/10
11:53
12/10/18
11:53
Hot Stocks
Breaking Hot Stocks news story on Embraer 

Embraer trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$165.31

-3.06 (-1.82%)

, QCOM

Qualcomm

$57.93

1.93 (3.45%)

11:53
12/10/18
12/10
11:53
12/10/18
11:53
Recommendations
Apple, Qualcomm analyst commentary  »

Qualcomm court win an…

AAPL

Apple

$165.31

-3.06 (-1.82%)

QCOM

Qualcomm

$57.93

1.93 (3.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,620.69

-8.5 (-0.52%)

, HAS

Hasbro

$82.87

-1.16 (-1.38%)

11:53
12/10/18
12/10
11:53
12/10/18
11:53
Hot Stocks
Amazon rolling out first private label toys for children, TJI says »

There appears to be an…

AMZN

Amazon.com

$1,620.69

-8.5 (-0.52%)

HAS

Hasbro

$82.87

-1.16 (-1.38%)

MAT

Mattel

$12.94

-0.5 (-3.72%)

JAKK

JAKKS Pacific

$2.18

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

DVA

DaVita

$57.23

-1.76 (-2.98%)

11:50
12/10/18
12/10
11:50
12/10/18
11:50
Options
6K DaVita Jan 67.5 - 72.5 call spreads trade 30c with shares at 52-week lows »

6K DaVita Jan 67.5 - 72.5…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
12/10/18
12/10
11:50
12/10/18
11:50
General news
Treasury's $75 B 3- and 6-month bill auctions were mixed »

Treasury's $75 B 3-…

ECL

Ecolab

$152.46

-1.66 (-1.08%)

11:47
12/10/18
12/10
11:47
12/10/18
11:47
Conference/Events
Ecolab management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

NTRI

Nutrisystem

$43.98

9.79 (28.63%)

, TVTY

Tivity Health

$28.11

-12.49 (-30.76%)

11:46
12/10/18
12/10
11:46
12/10/18
11:46
Downgrade
Nutrisystem, Tivity Health rating change  »

Nutrisystem downgraded to…

NTRI

Nutrisystem

$43.98

9.79 (28.63%)

TVTY

Tivity Health

$28.11

-12.49 (-30.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ALTM

Altus Midstream Company

$8.20

0.3 (3.80%)

11:45
12/10/18
12/10
11:45
12/10/18
11:45
Hot Stocks
Breaking Hot Stocks news story on Altus Midstream Company »

Capital Research reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

$118.38

-2.09 (-1.73%)

11:40
12/10/18
12/10
11:40
12/10/18
11:40
Hot Stocks
Mohawk director Filip Balcaen buys 22,900 shares of company stock »

Mohawk director Filip…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.